Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Introduction - General
Mantra Pharma Inc. including its subsidiaries (collectively "Mantra Pharma Inc" or the "Company") is committed to conducting its business in accordance with all applicable laws, rules and regulations and the highest ethical standards. The Board of Directors (the "Board") of the Company has determined that it should formalize its policy relating to anti-bribery and anti-corruption laws in the form of this "Anti-Bribery Policy" (the "Policy").
This Policy is designed to complement and expand on the Company's existing Code of Business Conduct which was approved on September 1, 2023 (the "Code of Business Conduct").
The complete Anti-Corruption Policy ("ACP") together with the Certificate of Compliance ("ACP-Cert--4-Signature") requiring signature) is available for you in our Document Library
It is important that the Company respect all international and local anti-bribery and anti-corruption laws, even where the perception is such that standards are loosely enforced by local authorities. Corrupt acts could expose the Company and its directors, officers and employees to the risk of prosecution, fines and imprisonment in Canada and in other countries where the Company does business. In addition, non-compliance threatens the Company's reputation, which plays a critical role in our success as a business.
This Policy applies to the worldwide conduct of all directors, officers and employees of the Company, wherever situated (collectively the "Employees"). This Policy also reflects the standard to which the Company expects Covered Third Parties, meaning all of the Company's partners, agents, consultants and other contractual counterparties, wherever situated, who interact with public officials on the Company's behalf, to adhere when acting on the Company's behalf. This Policy applies to Covered Third Parties. In addition to any other obligation, Covered Third Parties have all of the obligations set out in this Policy that apply to Employees.
Employees and Covered Third Parties must report, in person or in writing, any known or suspected violations of laws, governmental regulations, the Code of Business Conduct or this Policy to the Chair of the Audit Committee. Any questions or violation reports will be addressed immediately and seriously and can be made anonymously. If you feel uncomfortable reporting suspected violations to this individual, you may report matters to the Company's legal counsel, DuMoulin Black LLP. The addresses and telephone numbers of these reporting contacts are listed in Schedule "A" to this Policy.
NOTE: Upon reading of the complete Anti-Corruption Policy (provided in the Document Library), if you have any questions about the Policy or what is expected of our Interested Parties, please contact us (attention : "Chair of the Audit Committee" and "Company's President") for assistance using the Button (provided below) marked "Contact the President Re: Anti-Corruption Policy".
Copyright © 2024 Mantra Pharma Inc. - All Rights Reserved.
Designed by Ruhidesign
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.